| 2010 |
MON1A (and MON1B) are required for phagosome maturation: phagosomes in MON1A-deficient cells recruit RAB5 but fail to progress to the RAB7-positive stage. MON1 interacts with GTP-bound RAB5, identifying MON1 as a RAB5 effector. The MON1-CCZ1 complex (but not either protein alone) binds RAB7 and promotes RAB7 activation, functioning as a critical link in progression from RAB5-positive to RAB7-positive phagosome maturation. |
Genetic epistasis (C. elegans sand-1/ccz-1 mutants), mammalian cell knockdown, co-immunoprecipitation with GTP-bound RAB5, RAB7 binding assays, phagosome maturation imaging |
Nature |
High |
20305638
|
| 2007 |
MON1A is required for trafficking of ferroportin (the major mammalian iron exporter) to the macrophage cell surface, and is also important for trafficking of other cell-surface and secreted molecules, indicating a fundamental role in the mammalian secretory apparatus. |
QTL analysis in mice; missense allele co-segregation; cell-based trafficking assays with surface ferroportin measurement; siRNA knockdown |
Nature genetics |
High |
17632513
|
| 2012 |
MON1A acts in anterograde secretory trafficking: siRNA knockdown delays ER-to-Golgi traffic (shown by Endo H sensitivity of ts045VSVG-GFP), delays Golgi reformation after Brefeldin A treatment, and delays Golgi-to-plasma membrane trafficking. MON1A associates with dynein intermediate chain (identified by immunoprecipitation and mass spectrometry), and both MON1A and dynein reduction alter steady-state Golgi morphology. |
siRNA knockdown, Endo H assay, Brefeldin A washout, immunoprecipitation + mass spectrometry, immunofluorescence microscopy |
The Journal of biological chemistry |
High |
22665492
|
| 2020 |
MON1A/MON1B are components of the trimeric Mon1-Ccz1-C18orf8 (MCC) GEF complex for RAB7. MON1A/B-deficient cells lack RAB7 activation, show severe late endosome morphology defects, impaired endosomal LDL trafficking, and failure of NPC1-dependent lysosomal cholesterol export. Active RAB7 (downstream of MCC GEF activity) interacts with the NPC1 cholesterol transporter to license lysosomal cholesterol export. |
Genome-wide CRISPR screen, CRISPR knockout of MON1A/B and C18orf8, RAB7 activation assays, cholesterol reporter, late endosome morphology imaging, LDL trafficking assays, constitutively active RAB7 rescue |
Nature communications |
High |
33144569
|
| 2020 |
NRBF2 maintains CCZ1-MON1A GEF activity by interacting with the CCZ1-MON1A complex, regulating CCZ1-MON1A interaction with PI3KC3/VPS34 and CCZ1-associated PI3KC3 kinase activity; loss of NRBF2 impairs GTP-RAB7 generation and autophagosome maturation. MON1A also participates in the CCZ1-MON1A-RAB7 module that interacts with APP to facilitate degradation of APP-containing vesicles. |
Co-immunoprecipitation, RAB7-GTP pull-down assay, siRNA/KO of NRBF2, autophagosome maturation assay, APP-CTF degradation assay |
Autophagy |
Medium |
32543313
|
| 2022 |
MON1A-CCZ1 GEF activity is required for autophagosome maturation in Alzheimer disease models: active RAB7 is selectively decreased in autophagosome fractions from AD models, accompanied by impaired CCZ1-MON1A GEF activity. Overexpressing CCZ1-MON1A increases GTP-RAB7 levels, enhances autophagosome maturation, and promotes degradation of APP-CTFs, Aβ and P-tau in cells and a mouse AD model. |
GST-R7BD affinity-isolation assay for GTP-RAB7 in autophagosome fractions, AAV-mediated overexpression/knockdown of MON1A in mouse brain, immunoblotting, autophagosome purification, RNA-seq |
Theranostics |
Medium |
35198070
|
| 2022 |
The lysosomal V-ATPase a3 subunit interacts with MON1A-CCZ1 complex and recruits it to secretory lysosomes in osteoclasts. The interaction is mediated by the N-terminal half domain of a3 and the longin motifs of MON1A and CCZ1. Loss of a3 abolishes lysosomal localization of endogenous CCZ1, and exogenous expression of MON1A-CCZ1 GEF promotes the a3-RAB7 interaction. |
Co-immunoprecipitation in HEK293T cells, domain mapping (longin motif mutants), immunofluorescence of osteoclasts lacking a3 |
Scientific reports |
Medium |
35589873
|
| 2020 |
MON1A (via the CCZ1-MON1A complex) interacts with FYCO1 through the FYCO1 C-terminal GOLD domain, as identified by AP-MS and validated by co-immunoprecipitation; this interaction is required for RAB7A activation and fusion of autophagosomal/endosomal vesicles with lysosomes. |
Affinity purification-mass spectrometry (AP-MS) with spin-tip IMAC columns, co-immunoprecipitation validation |
Analytical chemistry |
Medium |
31992042
|
| 2023 |
FYCO1 interacts via its C-terminal GOLD domain with the CCZ1-MON1A complex; this interaction is necessary for RAB7A activation and lysosomal delivery of TNFRSF10B/TRAIL-R2. CASP8 cleaves FYCO1 at aspartate 1306, releasing the GOLD domain and inactivating FYCO1 function, thereby preventing further CCZ1-MON1A-dependent vesicle-lysosome fusion and allowing apoptosis to proceed. |
Co-immunoprecipitation (two-step), CRISPR KO of FYCO1, apoptosis assays, receptor trafficking/lysosomal degradation assays, caspase cleavage site identification |
Autophagy |
Medium |
37418591
|
| 2024 |
GORASP2 controls RAB7A activity by modulating its GEF complex MON1A-CCZ1, and this is required for RAB7A interaction with the HOPS complex and autophagosome-lysosome fusion during glucose starvation. |
Super-resolution microscopy, siRNA depletion of GORASP2, RAB7A activation assay, co-immunoprecipitation, SNARE complex assembly assay |
Autophagy |
Medium |
39056394
|
| 2023 |
MON1A is required for maintenance of Golgi ribbon architecture. MON1A interacts with the F-BAR protein FCHO2 (identified by yeast two-hybrid and co-immunoprecipitation). siRNA depletion of MON1A or FCHO2 causes Golgi fragmentation and prevents exchange of resident membrane proteins between Golgi ministacks (shown by FRAP). MON1A-silencing effect on Golgi disruption is cell cycle-independent, whereas FCHO2-silencing effect requires mitosis. |
Yeast two-hybrid, co-immunoprecipitation, siRNA knockdown, immunofluorescence, FRAP analysis |
bioRxivpreprint |
Medium |
37461455
|
| 2025 |
MON1A variants cause congenital diarrhea and enteropathy (CODE) in humans. Functional characterization in cell and zebrafish models demonstrated that MON1A loss-of-function results in intestinal disease, establishing MON1A as a novel CODE gene. |
Exome/genome sequencing of patient cohort, cell model functional assays, zebrafish loss-of-function models |
The New England journal of medicine |
Medium |
40174224
|